Does the FDA status of a proposed predicate device establish anything about this device before its own submission outcome?

Does the FDA status of a proposed predicate device establish anything about this device before its own submission outcome?

The company publishes no position under United States medical-device law, and no authority has approved, registered or endorsed the filter.

The label for the NanoFlashing™ Air Filter states that the filter is not a medical device and is not intended to diagnose, treat, cure or prevent disease. The Terms of Use state that, as of their effective date, the Medical devices chapter describes a Research Application, and that it does not describe a finished product currently available from C-POLAR for that use. They also state: “Do not use Site Content to diagnose, treat, or make a patient-care or infection-control decision,” and: “A laboratory reduction in a virus, bacterium, fungus, particle, or other endpoint does not establish a clinical benefit, fewer infections, disease prevention or treatment, or improved health.”

A submission for a finished device is made by the party that sponsors that device, for that device, and nothing held by another party carries over to it. The Terms of Use state: “A citation, quotation, name, logo, link, or third-party test does not by itself mean that the third party sponsors, endorses, certifies, or approves C-POLAR, a C-POLAR product, a Site claim, or a proposed use.”

Source: C-POLAR — Terms of Use, sections 3, 4 and 7, https://cpolar.tech/terms/; C-POLAR — NanoFlashing™ Medical, https://cpolar.tech/medical/; NanoFlashing™ Air Filter label.

Reviewed on 21 September 2026.